相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab as an adjuvant therapy for pemphigus: experience in 61 patients from a single center with long-term follow-up
Vinod K. Sharma et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Paradoxical reaction to rituximab in patients with pemphigus: a report of 10 cases
Ali Nili et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2020)
Effectiveness and safety analysis of rituximab in 146 Indian pemphigus patients: A retrospective single-center review of up to 68 months follow-up
Dipankar De et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2020)
Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center
Keshavamurthy Vinay et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Pascal Joly et al.
LANCET (2017)
Clinical effificacy of rituximab in the treatment of pemphigus: A retrospective study
Vinod Kumar Sharma et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2016)
Regulatory B10 cell development and function
Jacquelyn M. Lykken et al.
INTERNATIONAL IMMUNOLOGY (2015)
An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
K. T. Amber et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol
Kara Heelan et al.
JAMA DERMATOLOGY (2014)
Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients
Yael A. Leshem et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
Natacha Colliou et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Adjuvant Rituximab Therapy of Pemphigus
Luisa Lunardon et al.
ARCHIVES OF DERMATOLOGY (2012)
Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up
Giuseppe Cianchini et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Pemphigus in India
Amrinder J. Kanwar et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2011)
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee E. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris
Cheyda Chams-Davatchi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed
AS Belgi et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Rituximab: mechanisms and applications
PWM Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
